Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the incidence of contrast induced nephrotoxicity
following the administration of Isovue (iopamidol) or Visipaque in diabetic patients with
moderate to severe chronic renal impairment undergoing clinically indicated contrast enhanced
multidetector computed tomography (MDCT). Serum creatinine will be measured before and up to
48-72 hours post dose.